In-vitro equivalence [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2012-05-19 15:55 (5135 d 17:51 ago) – Posting: # 8590
Views: 6,122

Hi Martin,

❝ I would be really glad to get some ideas and suggestions!

❝ PPS.: it's a biologic - QbD :smoke:


OK. On basis of the info provided I am guessing that you could make a CI for the Test batches -each of them- and show that each CI spans over the PE for the single ref batch. You can plot CI limits and test's PE's as function of batch number (or better time of production?) and add a horizontal line depicting the ref.'s PE. The alphas prolly need qualification so that regulators know that you do not just chose the one that ensures that all CI's span across the ref's PE.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
200 visitors (0 registered, 200 guests [including 18 identified bots]).
Forum time: 09:46 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5